2013
DOI: 10.4088/jcp.13f08617
|View full text |Cite
|
Sign up to set email alerts
|

Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Duration of Gestation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…A single injection of bromodeoxyuridine at E12-E15 produces widespread changes in cerebral structure and function (Kolb et al, 2012). Prescription drug exposure during pregnancy in humans and other animals is also well known to affect anatomical and functional brain outcomes in offspring (Andrade, 2013a,b; Ungerer et al, 2013; Liew et al, 2014). The unique finding of the current study is the demonstration that sensory-motor experience of a dam during her pregnancy can influence the brain development and function in her offspring throughout the lifespan.…”
Section: Discussionmentioning
confidence: 99%
“…A single injection of bromodeoxyuridine at E12-E15 produces widespread changes in cerebral structure and function (Kolb et al, 2012). Prescription drug exposure during pregnancy in humans and other animals is also well known to affect anatomical and functional brain outcomes in offspring (Andrade, 2013a,b; Ungerer et al, 2013; Liew et al, 2014). The unique finding of the current study is the demonstration that sensory-motor experience of a dam during her pregnancy can influence the brain development and function in her offspring throughout the lifespan.…”
Section: Discussionmentioning
confidence: 99%
“…An important limitation of this strategy is that it assumes that the date of delivery can be pinpointed. If delivery is unexpectedly early, as may occur in antidepressant-treated women, 26,27 this strategy may not be implementable, and if delivery is delayed for any reason, prolongation of a low-dose or a drugfree period may risk relapse of depressive illness, which defeats the purpose of having exposed the offspring to the drug during pregnancy. The taperand-transiently-discontinue strategy is intuitively appealing, and a register-based study by Warburton et al 28 indeed found that respiratory distress and convulsions were each less likely to occur in neonates who had not been exposed to selective serotonin reuptake inhibitors in the 2 weeks before delivery (n = 2,122) relative to those who were exposed (n = 1,605); however, this finding disappeared in a propensity-matched analysis (n = 239 per group), implying that maternal illness characteristics may also drive the clinical features of PNAS.…”
Section: Practical Notes About Dosingmentioning
confidence: 99%